Gynecologic Oncology
Gynecologic Oncology - Related Videos
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
0 Views •
Cited by 14 •
2012
Stereotactic body radiotherapy (SBRT) involves image-guided, ablative radiation delivered to cancer targets refractory to chemotherapy or to conventional radiation treatment. The robotic-armed Cyberknife SBRT system, using sophisticated target localization, delivers hypofractionated radiation doses capable of sterilizing cancer targets. This article will consider new therapeutic roles of SBRT for gynecological cancers.
06:37
Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
0 Views •
Cited by 41 •
2010
Fluorescence imaging is a promising innovative modality for image-guided surgery in surgical oncology. In this video we describe the technical procedure for detection of the sentinel lymph node using fluorescence imaging as showcased in gynecologic oncologicy. A multispectral fluorescence camera system, together with the fluorescent agent indocyanine green, is applied.
11:18
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
0 Views •
Cited by 5 •
2011
A thoracic oncology database was developed to serve as a comprehensive repository for clinical and laboratory data for the purposes of translational research. The database will serve translational cancer researchers within the Thoracic Oncology Research Program. This database is adaptable to other cancer models, as well as other human diseases.
05:31
OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery
0 Views •
Cited by 6 •
2021
In vitro maturation (IVM) before gynecological operation (OP-IVM) combines IVM following oocyte retrieval with routine gynecological surgery and serves as an extension of conventional IVM applications for fertility preservation.
07:01
Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
0 Views •
Cited by 7 •
2020
The aim of this methodology is to identify cancer stem cells (CSC) in cancer cell lines and primary human tumor samples with the sphere-forming protocol, in a robust manner, using functional assays and phenotypic characterization with flow cytometry and Western blot.
FAQs
Staging estimates how far a cancer has spread and connects that information to treatment planning. Clinicians use findings from clinical evaluation, imaging, and pathology to determine whether an approach should emphasize surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Because stage reflects disease extent, it also helps organize prognosis and supports more individualized care.
Pathology characterizes the tumor, while tumor biology helps explain how that cancer behaves and may respond to treatment. These findings complement imaging and clinical assessment rather than standing alone. Together, they support individualized decisions and provide the scientific basis for using conventional treatments alongside targeted therapy or immunotherapy when appropriate.
Molecular classification groups tumors according to biological features identified through research. This approach can refine how cancers are characterized beyond their anatomic location and may support precision treatments tailored to tumor properties. In gynecologic oncology, ongoing work in molecular classification seeks to improve treatment selection and strengthen the connection between tumor biology and clinical care.
Treatment planning can consider more than tumor control. When appropriate, clinicians address fertility concerns, evaluate genetic risk, and incorporate quality-of-life goals into individualized care. These considerations help frame decisions around the patient’s broader circumstances, especially when treatment may affect reproductive function or when inherited risk has implications for the patient and family.
Evaluation begins with clinical assessment and proceeds through imaging, pathology, and staging. Clinical findings prompt further investigation, imaging helps assess disease, and pathology provides information about the tumor. Staging then integrates how far the cancer has spread, giving the care team a structured basis for selecting treatment and discussing individualized management.
These treatments may be selected according to the cancer’s extent, pathological findings, tumor biology, and the patient’s individual circumstances. Surgery, chemotherapy, and radiation represent established treatment options, while targeted therapy and immunotherapy reflect approaches informed by biological features and continuing research. Staging and clinical evaluation help determine which strategy or combination is appropriate.
Current research is refining screening, molecular classification, precision treatments, and supportive strategies. Screening research aims to improve detection, while molecular and precision approaches seek closer alignment between tumor characteristics and therapy. Supportive research addresses the experience of care and quality of life, helping advance outcomes for patients with complex reproductive cancers.